相似文献
1
Pro-inflammatory concerns with lipid nanoparticles.
Mol Ther. 2022 Jun 1;30(6):2109-2110. doi: 10.1016/j.ymthe.2022.04.011. Epub 2022 Apr 28.
2
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients.
Biomaterials. 2023 Jan;292:121930. doi: 10.1016/j.biomaterials.2022.121930. Epub 2022 Nov 29.
3
Tear of lipid membranes by nanoparticles.
Soft Matter. 2022 May 4;18(17):3318-3322. doi: 10.1039/d2sm00179a.
4
Cysteine-Encapsulated Liposome for Investigating Biomolecular Interactions at Lipid Membranes.
Int J Mol Sci. 2022 Sep 12;23(18):10566. doi: 10.3390/ijms231810566.
5
Analytical characterization of liposomes and other lipid nanoparticles for drug delivery.
J Pharm Biomed Anal. 2021 Jan 5;192:113642. doi: 10.1016/j.jpba.2020.113642. Epub 2020 Sep 19.
6
Lung targeted liposomes for treating ARDS.
J Control Release. 2022 Jun;346:421-433. doi: 10.1016/j.jconrel.2022.03.028. Epub 2022 Mar 28.
7
Micro- and nanoformulations of paclitaxel based on micelles, liposomes, cubosomes, and lipid nanoparticles: Recent advances and challenges.
Drug Discov Today. 2022 Feb;27(2):576-584. doi: 10.1016/j.drudis.2021.10.007. Epub 2021 Oct 21.
8
Lipid nanoparticle-based COVID-19 vaccines: Concerns about stability.
Am J Health Syst Pharm. 2022 Sep 7;79(18):1514-1515. doi: 10.1093/ajhp/zxac165.
9
Passive targeting of lipid-based nanoparticles to mouse cardiac ischemia-reperfusion injury.
Contrast Media Mol Imaging. 2013 Mar-Apr;8(2):117-26. doi: 10.1002/cmmi.1501.
10
Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
Artif Cells Nanomed Biotechnol. 2016;44(1):334-49. doi: 10.3109/21691401.2014.951721. Epub 2014 Sep 19.
引用本文的文献
1
Lipid-based nanoparticles: advancing therapeutic strategies for vitiligo management.
Bioimpacts. 2025 Jul 26;15:30860. doi: 10.34172/bi.30860. eCollection 2025.
2
Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape.
Nat Nanotechnol. 2025 Aug 11. doi: 10.1038/s41565-025-01974-5.
3
Discrete Immolative Guanidinium Transporters deliver mRNA to specific organs and red blood cells.
Nat Commun. 2025 Aug 1;16(1):7055. doi: 10.1038/s41467-025-62200-3.
4
Lipid nanoparticle-delivered IFNα2 activates Cxcl9 to increase T cell tumor recruitment to suppress lung metastasis.
J Immunother Cancer. 2025 Jul 31;13(7):e011415. doi: 10.1136/jitc-2024-011415.
5
Mannich reaction-based combinatorial libraries identify antioxidant ionizable lipids for mRNA delivery with reduced immunogenicity.
Nat Biomed Eng. 2025 Jul 18. doi: 10.1038/s41551-025-01422-8.
6
The secret life of RNA and lipids.
RNA Biol. 2025 Dec;22(1):1-28. doi: 10.1080/15476286.2025.2526903. Epub 2025 Jul 16.
7
Enhancing nucleic acid delivery by the integration of artificial intelligence into lipid nanoparticle formulation.
Front Med Technol. 2025 Jun 16;7:1591119. doi: 10.3389/fmedt.2025.1591119. eCollection 2025.
8
A Complete Approach for circRNA Therapeutics from Purification to Lyophilized Delivery Using Novel Ionizable Lipids.
Int J Mol Sci. 2025 May 27;26(11):5138. doi: 10.3390/ijms26115138.
9
Disulfide cross-linked redox-sensitive peptide condensates are efficient cell delivery vehicles of molecular cargo.
bioRxiv. 2025 May 23:2025.05.20.655132. doi: 10.1101/2025.05.20.655132.
10
Deconvolution of cargo delivery and immunogenicity following intranasal delivery of mRNA lipid nanoparticle vaccines.
Mol Ther Nucleic Acids. 2025 Apr 24;36(2):102547. doi: 10.1016/j.omtn.2025.102547. eCollection 2025 Jun 10.
本文引用的文献
1
IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines.
Nat Immunol. 2022 Apr;23(4):532-542. doi: 10.1038/s41590-022-01160-y. Epub 2022 Mar 24.
2
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory.
iScience. 2021 Dec 17;24(12):103479. doi: 10.1016/j.isci.2021.103479. Epub 2021 Nov 20.
3
From lipids to lipid nanoparticles to mRNA vaccines.
Nat Rev Mater. 2021;6(12):1075-1076. doi: 10.1038/s41578-021-00379-9. Epub 2021 Sep 21.
4
The tangled history of mRNA vaccines.
Nature. 2021 Sep;597(7876):318-324. doi: 10.1038/d41586-021-02483-w.
5
Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
Mol Ther. 2021 Mar 3;29(3):898-900. doi: 10.1016/j.ymthe.2021.01.030. Epub 2021 Feb 5.
6
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.
J Exp Med. 2018 Jun 4;215(6):1571-1588. doi: 10.1084/jem.20171450. Epub 2018 May 8.
7
The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation.
Biomaterials. 2010 Sep;31(26):6867-75. doi: 10.1016/j.biomaterials.2010.05.027. Epub 2010 Jun 11.
Zotero 插件